Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat

NCT03992014 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholestasis

Interventions

DRUG: Linerixibat tablet
DRUG: [14C]-linerixibat intravenous infusion
DRUG: Linerixibat oral solution

Sponsor

GlaxoSmithKline